| Medical and Health Sciences | Lifetime | 229 | US 124 | 99.99 |
| Applied Microbiology and Biotechnology | Lifetime | 1 | US 1 | 99.93 |
| Critical Care and Intensive Care Medicine | Lifetime | 3 | US 2 | 99.96 |
| Epidemiology | Lifetime | 88 | US 43 | 99.87 |
| Pulmonary and Respiratory Medicine | Lifetime | 247 | US 134 | 99.69 |
| Infectious Diseases | Lifetime | 192 | US 104 | 99.32 |
| Emergency Medicine | Lifetime | 136 | US 75 | 98.94 |
| Clinical Biochemistry | Lifetime | 122 | US 61 | 97.75 |
| Molecular Medicine | Lifetime | 91 | US 32 | 97.88 |
| Clinical Pharmacology | Lifetime | 562 | US 232 | 97.58 |
| Anesthesiology and Pain Medicine | Lifetime | 355 | US 173 | 93.51 |
| Emergency Medical Services | Lifetime | 733 | US 333 | 91.55 |
| Internal Medicine | Lifetime | 565 | US 239 | 76.98 |
| Critical Care and Intensive Care Medicine | 2021-2025 | 34 | US 13 | 97.49 |
| Epidemiology | 2021-2025 | 560 | US 194 | 94.85 |
| Molecular Medicine | 2021-2025 | 75 | US 11 | 91.37 |
| Applied Microbiology and Biotechnology | 2021-2025 | 63 | US 20 | 89.05 |
| Antibiotic Use and Resistance | Lifetime | 1 | US 1 | 99.97 |
| Pneumonia and Respiratory Infections | Lifetime | 2 | US 1 | 99.95 |
| Nosocomial Infections in ICU | Lifetime | 1 | US 1 | 99.98 |
| Healthcare Decision-Making and Restraints | Lifetime | 3 | US 1 | 99.64 |
| Respiratory Support and Mechanisms | Lifetime | 19 | US 8 | 99.89 |
| Sepsis Diagnosis and Treatment | Lifetime | 16 | US 7 | 99.86 |
| Emergency and Acute Care Studies | Lifetime | 20 | US 11 | 99.68 |
| Antibiotics Pharmacokinetics and Efficacy | Lifetime | 29 | US 16 | 99.76 |
| Intensive Care Unit Cognitive Disorders | Lifetime | 22 | US 10 | 99.76 |
| Bacterial Identification and Susceptibility Testing | Lifetime | 21 | US 12 | 99.79 |
| Antibiotic Resistance in Bacteria | Lifetime | 52 | US 19 | 99.77 |
| Antimicrobial Resistance in Staphylococcus | Lifetime | 37 | US 23 | 99.71 |
| Hemodynamic Monitoring and Therapy | Lifetime | 140 | US 53 | 98.86 |
| Family and Patient Care in Intensive Care Units | Lifetime | 80 | US 41 | 98.92 |
| Cardiac Arrest and Resuscitation | Lifetime | 369 | US 201 | 98.93 |
| Airway Management and Intubation Techniques | Lifetime | 228 | US 98 | 98.31 |
| Clostridium difficile and Clostridium perfringens research | Lifetime | 223 | US 110 | 98.14 |
| Antifungal resistance and susceptibility | Lifetime | 629 | US 236 | 96.98 |
| Anesthesia and Sedative Agents | Lifetime | 766 | US 320 | 96.54 |
| Streptococcal Infections and Treatments | Lifetime | 986 | US 415 | 95.61 |
| Inhalation and Respiratory Drug Delivery | Lifetime | 792 | US 316 | 95.29 |
| Healthcare Technology and Patient Monitoring | Lifetime | 518 | US 274 | 86.84 |
| Restraint-Related Deaths | Lifetime | 974 | US 380 | 80.31 |
| Nosocomial Infections in ICU | 2021-2025 | 13 | US 3 | 98.78 |
| Antibiotic Use and Resistance | 2021-2025 | 46 | US 14 | 98.47 |
| Pneumonia and Respiratory Infections | 2021-2025 | 69 | US 18 | 98.01 |
| Antibiotic Resistance in Bacteria | 2021-2025 | 132 | US 20 | 98.00 |
| Antibiotics Pharmacokinetics and Efficacy | 2021-2025 | 107 | US 25 | 96.14 |
| Bacterial Identification and Susceptibility Testing | 2021-2025 | 171 | US 36 | 94.19 |
| Sepsis Diagnosis and Treatment | 2021-2025 | 431 | US 99 | 93.60 |
| Emergency and Acute Care Studies | 2021-2025 | 893 | US 376 | 85.76 |
| Cystic Fibrosis Research Advances | 2021-2025 | 640 | US 213 | 86.78 |
